Training

Safe Motherhood Initiative

The Safe Motherhood Initiative seeks to reduce maternal mortality in India, the Philippines and Tibet.

Regional Hospital Management Program

The Johnson & Johnson Regional Hospital Management Program helps Asian hospital managers to improve their management and operations skills so their hospitals can deliver better health care services. Based in Singapore, the Regional Hospital Management Program is run jointly with Singapore Management University. Each year, professors from leading Singaporean and US teaching institutions review modern hospital management principles and techniques with 50 senior hospital administrators from different Asian countries during a five-day seminar.

Red Cross Children's Hospital, Cape Town

The Red Cross Children's Hospital is a leading center for pediatric services located in Cape Town that provides comprehensive health care to children and adolescents. Johnson & Johnson supplies educational, product and financial support. The company also funded the development of an educational center at the hospital, which educates hospital staff, as well as members of the Western Cape community on health-related issues.

Ranbaxy Community Health Care Society

Ranbaxy set up the Ranbaxy Community Health Care Society (RCHS) in 1994 as a professionally managed independent, nonprofit body. RCHS grew out of the work of the Ranbaxy Rural Development Trust, created by the company in 1979 to deliver primary health care to the underserved and underprivileged in Indian society and contribute to the national objective 'Health For All'. RCHS adopts a focused, integrated approach to basic health care issues its service areas.

Piramal: Helpyourbody Chronic Disease Campaign

India is the chronic disease capital of the world. The number of diabetics in the country is expected to rise from 40 million today to 70 million by 2025. In the same period, hypertensive cases are expected to rise from 118 million to 213.5 million, and cases of osteoarthritis from 15 million to 60 million. Genetic causes, obesity, stress, inappropriate dietary habits and a lack of exercise predispose India to such chronic ailments in a relatively young population.

Pfizer Global Health Partnerships

Pfizer has a responsibility to direct its resources and expertise to address the world's most enduring health challenges. Cancer is one of these challenges and Pfizer recognizes that only by working together with those who share a vision of a healthier world can we make a significant impact toward eradicating this disease that has outlived too many generations. Pfizer's Global Health Partnerships (GHP) Program is one approach it is taking to tackle the global cancer epidemic.

Pfizer Global Health Fellows

The Pfizer Global Health Fellows program utilizes the professional expertise of Pfizer employees through specialized volunteer assignments with nonprofit organizations to improve health care services for underserved communities around the world. Since 2003, more than 230 employees with a range of technical skills have served in 39 nations for 3-6 month assignments investing nearly 200,000 hours of skills-based service to help increase the capacity of nonprofits organizations providing health care to the underserved (in the reporting period, 54 Global Health Fellows were deployed).

Pfizer Diflucan Partnership

Pfizer created the Diflucan Partnership in 2000 to provide treatment for two AIDS-related fungal infections in developing countries. Since the program's inception, Pfizer has over provided USD 1.1 billion of products and its program partners distribute millions of Diflucan (fluconazole) treatments free of charge to governments and NGOs in 63 developing countries in Africa, Asia, the Caribbean and Latin America. Pfizer has also provided training and education materials to 20,000 healthcare professionals.

Pfizer - Mobilize Against Malaria

Unveiled at the Clinton Global Initiative in 2006, Mobilize Against Malaria is Pfizer's signature social investment in malaria, supporting programs to reduce the malaria burden in three hard-hit African countries, Ghana, Kenya and Senegal, over a five year period (2007-2011). Under this USD 15 million program, Pfizer helps four leading NGOs to close critical gaps in malaria treatment, training, and public demand for quality services. In Ghana, Pfizer is helping to bring the public and private sectors together to find new solutions to the malaria challenge.

Pfizer - Infectious Diseases Institute

The Infectious Diseases Institute (IDI) in Kampala, Uganda was established in 2004 as a Center of Excellence in Infectious Disease, combining a research program, innovative training program, and locally relevant strategies for prevention, treatment & care, to build regional capacity to address HIV/AIDS, malaria and tuberculosis. Partners in the IDI include Accordia Global Health Foundation, Makerere University and Mulago Hospital, the Ugandan Ministry of Health, and the Infectious Diseases Society of America.

Pages